AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20419592 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (n = 6)
Number of subjects: 11
Study 20419592 — intervention group
Group type: COMPARATOR
Intervention: Control group (normoxia, n = 5)
Number of subjects: 11
Study 18097177 — intervention group
Group type: COMPARATOR
Intervention: Orbital radiotherapy alone
Number of subjects: 18
Study 18097177 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy
Number of subjects: 18
Study 18097177 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy combined with oral corticosteroids
Number of subjects: 18
Study 18097177 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy combined with intravenous methylprednisolone
Number of subjects: 18
Study 15966883 — intervention group
Group type: EXPERIMENTAL
Intervention: AmF/SnF(2) dentifrice-mouth rinse combination
Number of subjects: 281
Study 15966883 — intervention group
Group type: COMPARATOR
Intervention: NaF-containing dentifrice
Number of subjects: 281
Study 12693349 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (Transcutaneous Electrical Nerve Stimulation)
Number of subjects: 0
Study 10471987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (20 mg)
Number of subjects: 0
Study 10471987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride with Pantoprazole (40 mg)
Number of subjects: 0
Study 10471987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride alone and with Pantoprazole
Number of subjects: 0
Study 9185249 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/AIDS educational pamphlet distributed to every household in 12 villages in spring 1992
Number of subjects: 954
Study 9185249 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/AIDS educational pamphlet
Number of subjects: 954
Study 9185249 — intervention group
Group type: COMPARATOR
Intervention: Secular trends and increased communication between villagers
Number of subjects: 954
Study 8335505 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha priming followed by IFN-alpha therapy (10 MU thrice-weekly for three months)
Number of subjects: 37
Study 8335505 — intervention group
Group type: COMPARATOR
Intervention: IFN-alpha therapy (10 MU thrice-weekly for three months)
Number of subjects: 37
Study 3743147 — intervention group
Group type: EXPERIMENTAL
Intervention: Instillation of 50 ml of 0.1 N hydrochloric acid in Group 3
Number of subjects: 39
Study 3743147 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine pretreatment (0.01 mg/kg twice daily) followed by instillation of acid in Group 3
Number of subjects: 39
Study 3743147 — intervention group
Group type: COMPARATOR
Intervention: Instillation of 50 ml of isotonic sodium chloride solution
Number of subjects: 39
Study 31243870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention during radiotherapy
Number of subjects: 15
Study 29596950 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based lifestyle intervention (GLI)
Number of subjects: 331
Study 29596950 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based lifestyle intervention (GLI) attendance
Number of subjects: 331
Study 29596950 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 331
Study 27567918 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane (up to 6 mL)
Number of subjects: 204
Study 27567918 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 204
Study 27567918 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane
Number of subjects: 204
Study 27567918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 24837215 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 340
Study 24837215 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 340
Study 22679908 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianeptine (37.5 mg) with probiotics (Bacillus subtilis + Streptococcus faecium)
Number of subjects: 228
Study 22679908 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (10 mg) with probiotics (Bacillus subtilis + Streptococcus faecium)
Number of subjects: 228
Study 20081065 — intervention group
Group type: COMPARATOR
Intervention: Single ascending dose (SAD) of edoxaban (10, 30, 60, 90, 120, 150 mg)
Number of subjects: 121
Study 20081065 — intervention group
Group type: COMPARATOR
Intervention: Multiple ascending dose (MAD) of edoxaban (90 mg daily, 60 mg twice daily, 120 mg daily)
Number of subjects: 121
Study 20081065 — intervention group
Group type: COMPARATOR
Intervention: Edoxaban (both SAD and MAD)
Number of subjects: 121
Study 18316122 — intervention group
Group type: EXPERIMENTAL
Intervention: Hostile priming condition
Number of subjects: 196
Study 18316122 — intervention group
Group type: COMPARATOR
Intervention: Neutral priming condition
Number of subjects: 196
Study 18316122 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal exposure to hostility-related words (Experiment 2)
Number of subjects: 196
Study 18316122 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraliminal exposure to hostility-related words (Experiment 1)
Number of subjects: 196
Study 15951655 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (maximum dose 24 mg/day)
Number of subjects: 91
Study 15951655 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin (2400 mg/day)
Number of subjects: 91
Study 12546606 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine kinase (CK) measurement
Number of subjects: 152
Study 12546606 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac troponin I and T measurement
Number of subjects: 152
Study 12546606 — intervention group
Group type: EXPERIMENTAL
Intervention: CK-MB measurement
Number of subjects: 152
Study 10229489 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% metoclopramide
Number of subjects: 40
Study 10229489 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% droperidol
Number of subjects: 40
Study 10229489 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 40
Study 8934107 — intervention group
Group type: EXPERIMENTAL
Intervention: 2500 XaI units of low molecular weight heparin daily
Number of subjects: 2070
Study 8934107 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 XaI units of low molecular weight heparin daily
Number of subjects: 2070
Study 1930768 — intervention group
Group type: EXPERIMENTAL
Intervention: Methanol exposure at 250 mg/m3 for 75 minutes
Number of subjects: 12
Study 1930768 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 12
Study 6131124 — intervention group
Group type: EXPERIMENTAL
Intervention: Quitting smoking during the year following hospitalization
Number of subjects: 157
Study 6131124 — intervention group
Group type: EXPERIMENTAL
Intervention: Using psychotropic drugs (benzodiazepines)
Number of subjects: 157
Study 6131124 — intervention group
Group type: EXPERIMENTAL
Intervention: High psychosocial stress levels one year after discharge
Number of subjects: 157
Study 6131124 — intervention group
Group type: COMPARATOR
Intervention: Stress
Number of subjects: 157
Study 6131124 — intervention group
Group type: COMPARATOR
Intervention: Quitting smoking
Number of subjects: 157
Study 31123862 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g bovine colostrum for 4.5 hours
Number of subjects: 16
Study 31123862 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g bovine colostrum per day for 4 weeks
Number of subjects: 16
Study 31123862 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g bovine colostrum per day for 12 weeks
Number of subjects: 16
Study 31123862 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4.5 hours
Number of subjects: 16
Study 31123862 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 16
Study 31123862 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 16
Study 31271359 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced unit dose of rabies immunoglobulin (RIG) for class 3 rabid animal bites
Number of subjects: 0
Study 31271359 — intervention group
Group type: COMPARATOR
Intervention: Standard of research methodology (randomised controlled trial)
Number of subjects: 0
Study 28789655 — intervention group
Group type: EXPERIMENTAL
Intervention: New elastic cuff
Number of subjects: 63
Study 28789655 — intervention group
Group type: COMPARATOR
Intervention: Conventional cuff
Number of subjects: 63
Study 26033066 — intervention group
Group type: EXPERIMENTAL
Intervention: Porous titanium granules
Number of subjects: 20
Study 26033066 — intervention group
Group type: COMPARATOR
Intervention: Autograft bone
Number of subjects: 20
Study 24291047 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight humeral nail (MultiLoc, Synthes)
Number of subjects: 54
Study 24291047 — intervention group
Group type: COMPARATOR
Intervention: Curvilinear nail (Polarus, Acumed)
Number of subjects: 54
Study 24291047 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study 23276084 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Cawthorne&Cooksey protocol
Number of subjects: 68
Study 23276084 — intervention group
Group type: COMPARATOR
Intervention: Multimodal Cawthorne&Cooksey protocol
Number of subjects: 68
Study 19482890 — intervention group
Group type: EXPERIMENTAL
Intervention: Real taping
Number of subjects: 16
Study 19482890 — intervention group
Group type: COMPARATOR
Intervention: No taping
Number of subjects: 16
Study 19482890 — intervention group
Group type: COMPARATOR
Intervention: Placebo taping
Number of subjects: 16
Study 17552299 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 403
Study 17552299 — intervention group
Group type: COMPARATOR
Intervention: Conventional restorative treatment using rotary instruments (750 rpm)
Number of subjects: 403
Study 15117306 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulphadoxine plus probenecid (20-25 mg/kg in two divided doses daily for 3 days)
Number of subjects: 151
Study 15117306 — intervention group
Group type: COMPARATOR
Intervention: Pyrimethamine-sulphadoxine (25 mg/kg of the sulphadoxine component)
Number of subjects: 151
Study 15117306 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulphadoxine plus probenecid
Number of subjects: 151
Study 15117306 — intervention group
Group type: COMPARATOR
Intervention: Pyrimethamine-sulphadoxine
Number of subjects: 151
Study 15117306 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 151
Study 11453853 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV with perfluorodecalin (study, n=12)
Number of subjects: 24
Study 11453853 — intervention group
Group type: COMPARATOR
Intervention: PPV without perfluorodecalin (control, n=12)
Number of subjects: 24
Study 9704688 — intervention group
Group type: EXPERIMENTAL
Intervention: On-vasodilator group
Number of subjects: 32
Study 9704688 — intervention group
Group type: COMPARATOR
Intervention: Off-vasodilator group
Number of subjects: 32
Study 7803248 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg 500 mg/kg every 4 weeks for 1 year
Number of subjects: 34
Study 7803248 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg 250 mg/kg every 4 weeks for 1 year
Number of subjects: 34
Study 7803248 — intervention group
Group type: COMPARATOR
Intervention: Placebo (from previous study)
Number of subjects: 34
Study 3053668 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 43
Study 3053668 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 43
Study 31553946 — intervention group
Group type: EXPERIMENTAL
Intervention: 5A's model for PA counseling with weekly motivational text messages
Number of subjects: 59
Study 31553946 — intervention group
Group type: COMPARATOR
Intervention: Fitbit only (Control)
Number of subjects: 59
Study 28007790 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive Writing Intervention (EWI)
Number of subjects: 295
Study 28007790 — intervention group
Group type: COMPARATOR
Intervention: Neutral Writing Control
Number of subjects: 295
Study 26215384 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycled lighting system in ICU room
Number of subjects: 119
Study 26215384 — intervention group
Group type: COMPARATOR
Intervention: Ordinary lighting environment in ICU room
Number of subjects: 119
Study 26215384 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycled lighting environment
Number of subjects: 119
Study 24074607 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic products (minced and granule forms)
Number of subjects: 0
Study 24074607 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese freeze-dried garlic
Number of subjects: 0
Study 24074607 — intervention group
Group type: EXPERIMENTAL
Intervention: Allyl disulphide
Number of subjects: 0
Study 24074607 — intervention group
Group type: COMPARATOR
Intervention: Levamisole (control)
Number of subjects: 0
Study 24074607 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic products (general)
Number of subjects: 0
Study 21950394 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant massage
Number of subjects: 0
Study 21950394 — intervention group
Group type: COMPARATOR
Intervention: Standard care only (comparison group)
Number of subjects: 0
Study 18997911 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop
Number of subjects: 20
Study 18997911 — intervention group
Group type: EXPERIMENTAL
Intervention: VivaSens
Number of subjects: 20
Study 18997911 — intervention group
Group type: EXPERIMENTAL
Intervention: Copalite
Number of subjects: 20
Study 18997911 — intervention group
Group type: COMPARATOR
Intervention: Unlined restorations
Number of subjects: 20
Study 17159028 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for glaucoma (cataract extraction)
Number of subjects: 607
Study 17159028 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment for glaucoma
Number of subjects: 607
Study 12897178 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME (4 mg kg-1 in 50 ml saline over 60 min)
Number of subjects: 7
Study 12897178 — intervention group
Group type: COMPARATOR
Intervention: Control (without L-NAME)
Number of subjects: 7
Study 10636614 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 degree Trendelenburg position with head straight
Number of subjects: 15
Study 10636614 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 degree Trendelenburg position with head rotated to the right
Number of subjects: 15
Study 10636614 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 degree Trendelenburg position with head rotated to the left
Number of subjects: 15
Study 10636614 — intervention group
Group type: EXPERIMENTAL
Intervention: Head flexed and rotated to the right
Number of subjects: 15
Study 10636614 — intervention group
Group type: EXPERIMENTAL
Intervention: Head flexed and rotated to the left
Number of subjects: 15
Study 8874841 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan-free amino acid mixture
Number of subjects: 12
Study 8874841 — intervention group
Group type: COMPARATOR
Intervention: All essential amino acids mixture (control)
Number of subjects: 12
Study 1528102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous PCA (IPCA)
Number of subjects: 20
Study 1528102 — intervention group
Group type: COMPARATOR
Intervention: Epidural PCA (EPCA)
Number of subjects: 20
Study 3698693 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg orally)
Number of subjects: 9
Study 30975627 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib plus bevacizumab (150 mg per day erlotinib + 15 mg/kg bevacizumab once every 21 days)
Number of subjects: 228
Study 30975627 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib alone (150 mg per day)
Number of subjects: 228
Study 29905969 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation, adjusted to maintain serum 25(OH)D above 75 nmol/L
Number of subjects: 260
Study 29905969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 26725183 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed plus Cisplatin followed by Gefitinib (PC/G)
Number of subjects: 236
Study 26725183 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib monotherapy (G)
Number of subjects: 236
Study 25168762 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week sports-oriented exercise programme
Number of subjects: 0
Study 25168762 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-delivered self-help tool to promote and support sports participation
Number of subjects: 0
Study 25168762 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sports-oriented exercise programme and web-delivered self-help tool
Number of subjects: 0
Study 25168762 — intervention group
Group type: COMPARATOR
Intervention: Standard care general practitioner referral for gym-based exercise (Control)
Number of subjects: 0
Study 22442436 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed dexamethasone (6 monthly pulses)
Number of subjects: 39
Study 22442436 — intervention group
Group type: COMPARATOR
Intervention: Daily prednisolone (8 months)
Number of subjects: 39
Study 22442436 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed dexamethasone
Number of subjects: 39
Study 22442436 — intervention group
Group type: COMPARATOR
Intervention: Daily prednisolone
Number of subjects: 39
Study 22442436 — intervention group
Group type: COMPARATOR
Intervention: None (treatment-nonresponsive patients)
Number of subjects: 39
Study 20089781 — intervention group
Group type: EXPERIMENTAL
Intervention: Active malaria morbidity management (trial group)
Number of subjects: 929
Study 20089781 — intervention group
Group type: COMPARATOR
Intervention: Control group (no active malaria morbidity management)
Number of subjects: 929
Study 17700050 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Dynamic Therapy (BDT) combined with antidepressants
Number of subjects: 35
Study 17700050 — intervention group
Group type: COMPARATOR
Intervention: Supportive Psychotherapy (BSP) combined with antidepressants
Number of subjects: 35
Study 15969353 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (Mph)
Number of subjects: 43
Study 15969353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 12874937 — intervention group
Group type: EXPERIMENTAL
Intervention: NIC reminiscence intervention
Number of subjects: 30
Study 12874937 — intervention group
Group type: COMPARATOR
Intervention: Customary reminiscence intervention
Number of subjects: 30
Study 11820944 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 91
Study 11820944 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium
Number of subjects: 91
Study 11820944 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol + Ipratropium
Number of subjects: 91
Study 8674228 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 micrograms applied to one nostril daily for 3 weeks)
Number of subjects: 12
Study 8674228 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (200 micrograms applied to one nostril daily for 3 weeks)
Number of subjects: 12
Study 8674228 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo (applied to the other nostril)
Number of subjects: 12
Study 2061366 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 13
Study 2061366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 6367013 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy (SGV)
Number of subjects: 685
Study 6367013 — intervention group
Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy (PCV)
Number of subjects: 685
Study 6367013 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy (SGV) and Parietal cell vagotomy (PCV)
Number of subjects: 685
Study 30849343 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemetric IOP measurement using Eyemate-IO sensor
Number of subjects: 12
Study 30849343 — intervention group
Group type: COMPARATOR
Intervention: Finger palpation for IOP assessment
Number of subjects: 12
Study 29580348 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic mesh repair
Number of subjects: 208
Study 29580348 — intervention group
Group type: COMPARATOR
Intervention: Primary suture repair
Number of subjects: 208
Study 26419675 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth subgingival ultrasonic instrumentation followed by Er:YAG laser application 1 week later to sites with initial probing pocket depth ≥4.5 mm
Number of subjects: 40
Study 26419675 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth ultrasonic subgingival instrumentation within 1 week
Number of subjects: 40
Study 25082715 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (10mg)
Number of subjects: 14
Study 25082715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 21762561 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive PEEP at 5 cm H(2)O
Number of subjects: 30
Study 21762561 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive PEEP at 10 cm H(2)O
Number of subjects: 30
Study 21762561 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive PEEP at 15 cm H(2)O
Number of subjects: 30
Study 21762561 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-support ventilation (PSV) at 5 cm H(2)O
Number of subjects: 30
Study 21077346 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine CR (NCR) dose uptitration (VAL 80 mg + NCR 40 mg)
Number of subjects: 31
Study 21077346 — intervention group
Group type: COMPARATOR
Intervention: Valsartan (VAL) dose uptitration (VAL 160 mg + NCR 20 mg)
Number of subjects: 31
Study 21077346 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine CR (NCR) dose uptitration
Number of subjects: 31
Study 21077346 — intervention group
Group type: COMPARATOR
Intervention: Valsartan (VAL) dose uptitration
Number of subjects: 31
Study 17568867 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg/day for three days, n = 49)
Number of subjects: 109
Study 17568867 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (500 mg every eight hours for ten days, n = 53)
Number of subjects: 109
Study 15697042 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency 10 Hz rTMS over 10 days
Number of subjects: 20
Study 15697042 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study 12389708 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleic Acid Sequence‐Based Amplification (NASBA) assay on blood cultures after 2 days of culturing
Number of subjects: 10